Gene Signature Predicts Outcomes in HPV-Related Oropharyngeal Cancers
HPV gene signature was associated with outcomes in patients with HPV-related oropharyngeal cancers and could become a prognostic biomarker.
Oropharyngeal Cancer
As HPV-Related Cancer Rates Climb, Experts Scrutinize Barriers to HPV Vaccination
Oropharyngeal cancers have become the most common HPV-associated malignancies in the US, where the rate of vaccination against HPV lags compared with other countries.
Phase 1b/2 Study of DPX-E7 + Cyclophosphamide in HPV-positive Cancers
Researchers are evaluating whether DPX-E7 vaccination is safe and will improve outcomes among patients with HPV-positive head and neck, cervical, or anal cancer.
Phase 2 Study of ADXS 11-001 Vaccination in HPV-positive Oropharyngeal Squamous Cell Carcinoma
Researchers are evaluating whether ADXS 11-001 vaccination prior to transoral surgery will improve outcomes for patients with HPV-positive oropharyngeal cancer.
TORS May Improve Swallowing Function in Patients With Oropharyngeal Cancer
Findings suggest that TORS is a promising strategy for improving swallowing function in patients with OPSCC, without compromising disease-free survival.
New Staging System for HPV-positive Oropharyngeal Cancer Proposed
The ICON-S developed a TNM classification specific to human papillomavirus (HPV)-related oropharyngeal cancer.
HPV-16 in Oral Cavity Associated With Increased Risk of Oropharyngeal Squamous Cell Carcinoma
Detection of human papillomavirus (HPV)-16 in the oral cavity may be associated with 22-times increased risk of oropharyngeal squamous cell carcinoma.
HPV16+ Patients With Oropharyngeal Squamous Cell Cancer Survive Longer Than HPV- Patients
Human papillomavirus 16 (HPV16)-positive patients with oropharyngeal squamous cell cancer (OPSCC) survive longer than HPV-negative patients.
Veterans May Face Poorer Oral, Throat Cancer Outcomes
In veterans, oropharyngeal squamous cell carcinoma (SCC) is associated with traditional carcinogens and poor clinical outcomes.
HPV16 DNA Rinse Post Treatment Could Predict Recurrence
Human papillomavirus (HPV) type 16 DNA in oral rinses is common at diagnosis, but rare after treatment for HPV oropharyngeal carcinoma (OPC).
Next post in Head and Neck Cancer
